The systemic inflammatory response in cancer patients contributes to reduced iron metabolism, diminished response to erythropoietin, and decreased red blood cell survival, which may explain the symptoms and clinical signs in cancer patients: weight loss, anorexia, and cancer-related anemia [8, 9]. Here, EPO is linked to cancer.